Table 4
Author, date and countryPatient groupStudy type (level of evidence)OutcomesKey resultsStudy weaknesses
Mackenzie SJ et al 1990 Scotland2 patients with RSE. Standard treatment unsuccesfulCase seriesObservation of seizure activityPropofol stopped seizure activity clinically and on EEGCase series
Campostrini R et al 1991 Italy4 patients on ICU with RSECase seriesObservation of seizure activityPropofol infusion stopped apparent seizure activityCase series
Borgeat A et al 1994 SwitzerlandAdult OD patient. Propofol was given to suppress EEG activityCase reportObservation of EEG activityPropofol appeared to suppress EEG seizure activityCase report
Kuisma M and Roine RO 1995 Finland8 adult patients in prehospital care with RSE. All patients were intubated and ventilated. All received propofol boluses of 100–200 mg.Case seriesSuccess at terminating seizuresAll patients stopped RSE with propofolCase series. Not clear if patients intubated before or after propofol usage. This could be a result of the use of propofol.
Harrison AM et al 1998 USA9/12 child with hereditary fructose intolerance in RSECase reportObservationRSE stopped on infusion of 3 mg/kg propofolCase report Rare underlying disorder
Stecker MM et al 1998 USA16 Adult patients with RSE. All patients intubated.Open trialTime to seizure termination (elimination of EEG and clinical seizures)Thiopentone 123 min vs propofol 2.6 min (p=0.002)Open trial. Some of the propofol patients part of another trial. others identified retrospectively.
Thiopentone (8) v propofol (8) 1mg/kg over 5 min, repeated if needed.Success at terminating seizuresThiopentone 82% v propofol 63% (NS)Very small trial